High SNHG12 expression level was first confirmed in pancreatic cancer tissues and cell lines using qRT-PCR, which suggested that SNHG12 could be invoked as a biomarker for early diagnosis of pancreatic cancer. This evidence concerns the gene SNHG12 and familial pancreatic carcinoma.